Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy.
Kourakis S, Timpani CA, de Haan JB, Gueven N, Fischer D, Rybalka E. Kourakis S, et al. Among authors: fischer d. Redox Biol. 2021 Jan;38:101803. doi: 10.1016/j.redox.2020.101803. Epub 2020 Nov 18. Redox Biol. 2021. PMID: 33246292 Free PMC article. Review.
Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.
Hafner P, Bonati U, Erne B, Schmid M, Rubino D, Pohlman U, Peters T, Rutz E, Frank S, Neuhaus C, Deuster S, Gloor M, Bieri O, Fischmann A, Sinnreich M, Gueven N, Fischer D. Hafner P, et al. Among authors: fischer d. PLoS One. 2016 Jan 22;11(1):e0147634. doi: 10.1371/journal.pone.0147634. eCollection 2016. PLoS One. 2016. PMID: 26799743 Free PMC article. Clinical Trial.
Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
Hafner P, Bonati U, Klein A, Rubino D, Gocheva V, Schmidt S, Schroeder J, Bernert G, Laugel V, Steinlin M, Capone A, Gloor M, Bieri O, Hemkens LG, Speich B, Zumbrunn T, Gueven N, Fischer D. Hafner P, et al. Among authors: fischer d. JAMA Netw Open. 2019 Oct 2;2(10):e1914171. doi: 10.1001/jamanetworkopen.2019.14171. JAMA Netw Open. 2019. PMID: 31664444 Free PMC article. Clinical Trial.
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Kourakis S, Timpani CA, de Haan JB, Gueven N, Fischer D, Rybalka E. Kourakis S, et al. Among authors: fischer d. Pharmaceuticals (Basel). 2020 Oct 13;13(10):306. doi: 10.3390/ph13100306. Pharmaceuticals (Basel). 2020. PMID: 33066228 Free PMC article. Review.
Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
Bonati U, Hafner P, Schädelin S, Schmid M, Naduvilekoot Devasia A, Schroeder J, Zuesli S, Pohlman U, Neuhaus C, Klein A, Sinnreich M, Haas T, Gloor M, Bieri O, Fischmann A, Fischer D. Bonati U, et al. Among authors: fischer d. Neuromuscul Disord. 2015 Sep;25(9):679-85. doi: 10.1016/j.nmd.2015.05.006. Epub 2015 Jun 4. Neuromuscul Disord. 2015. PMID: 26096788
Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysis.
Schmidt S, Hafner P, Klein A, Rubino-Nacht D, Gocheva V, Schroeder J, Naduvilekoot Devasia A, Zuesli S, Bernert G, Laugel V, Bloetzer C, Steinlin M, Capone A, Gloor M, Tobler P, Haas T, Bieri O, Zumbrunn T, Fischer D, Bonati U. Schmidt S, et al. Among authors: fischer d. Neuromuscul Disord. 2018 Jan;28(1):16-23. doi: 10.1016/j.nmd.2017.10.003. Epub 2017 Nov 21. Neuromuscul Disord. 2018. PMID: 29174526 Clinical Trial.
2,363 results